Task: Answer the multiple-choice question.
Question: Which drug exhibits a 1.734\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Cc1c(Cl)cccc1-n1c(SCC(=O)N2CCC(C(=O)O)CC2)nnc1-c1ccncc1
b.) Cc1ccc(NC(=O)c2cc3c(=O)oc4ccccc4c3s2)nc1
c.) CCSc1nsc(NC(=O)Nc2cccc(C(C)=O)c2)n1
Answer: b. Cc1ccc(NC(=O)c2cc3c(=O)oc4ccccc4c3s2)nc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)c2cc3c(=O)oc4ccccc4c3s2)nc1
Cc1ccc(NC(=O)c2cc3c(=O)oc4ccccc4c3s2)nc1
N-(5-methylpyridin-2-yl)-4-oxothieno[3,2-c]chromene-2-carboxamide